Fixed combination of lercanidipine and enalapril in the management of hypertension: focus on patient preference and adherence
Authors:
Open Access
- 1 June 2012
- journal article
- review article
- Published by Taylor & Francis in Patient Preference and Adherence
- Vol. 6, 449-455
Abstract
Peer reviewed article authored by (Borghi C, Santi F). Read article or submit your manuscript for publishing.Keywords
This publication has 61 references indexed in Scilit:
- Effective management of hypertension with dihydropyridine calcium channel blocker-based combination therapy in patients at high cardiovascular riskInternational Journal Of Clinical Practice, 2008
- A Randomized, Double-Blind Comparison of Lercanidipine 10 and 20 mg in Patients with Stable Effort AnginaAmerican Journal of Therapeutics, 2004
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 ReportJAMA, 2003
- Vasodilatory edema: A common side effect of antihypertensive therapyCurrent Cardiology Reports, 2002
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- Effect of Ramipril vs Amlodipine on Renal Outcomes in Hypertensive NephrosclerosisA Randomized Controlled TrialJAMA, 2001
- Ace inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertensionAmerican Journal of Hypertension, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998